On Demand: Preparing for the Ambulatory Specialty Model-Heart Failure: Strategic Readiness for CV Programs-Webinar Slides

Webinar Slides

Pdf Summary

The document outlines policy and operational readiness guidance for Medicare’s new mandatory Alternative Specialty Model (ASM) for Heart Failure (HF), a 5-year CMMI demonstration aimed at expanding specialty value-based care. ASM-HF is <strong>not a reporting program</strong>; it is an episode-based accountability model with <strong>individual physician (NPI-level) financial risk</strong> and <strong>two-sided payment adjustments</strong>. CMS will compare cardiologists in selected geographic areas on <strong>five quality measures</strong> and a <strong>HF episode-based cost measure</strong>, with <strong>quality and cost weighted 50/50</strong>. Participants are <strong>waived from MIPS/MVP reporting</strong> during ASM performance years.

Key timing: final rule changes were released/ finalized in late 2025, selected geographic areas and preliminary participant lists appear in early 2026, the final participant list is expected July 2026, the <strong>performance period begins Jan. 1, 2027</strong>, and <strong>payment adjustments begin in 2029</strong>, creating a “2-year blind spot” between performance and payment.

Eligibility is assessed <strong>annually</strong> and requires: billing under the Medicare Physician Fee Schedule, cardiology specialty (PECOS), location in a mandatory CBSA, and a <strong>20-episode threshold</strong> of Medicare HF patients using CMS’s episode logic. A critical and often-missed requirement is <strong>prescription confirmation</strong>: attribution/eligibility depends on visible prescribing activity under the cardiologist’s NPI (e.g., shared prescribing under an APP or PCP can prevent attribution). Small denominators near the threshold create volatility and higher risk.

Quality measures include HF medication measures (beta-blocker; ACEi/ARB/ARNI for LVSD), blood pressure control, functional status assessments (KCCQ or MLHFQ—**license required**), and a claims-based CV admission measure. Cost includes broad Medicare-covered services across acute, post-acute, outpatient, DME, Part D, etc., much of which occurs outside the clinic.

Payment adjustments range <strong>–9% to +9%</strong> (risk rising in later years) and are funded through <strong>Part B payment reductions</strong> that create an incentive pool (redistribution model; upside funded by downside). Recommended readiness actions include validating rosters using the CMS dataset, stabilizing denominators, reconciling panels vs attributed episodes, formalizing collaborative care workflows, building physician-level shadow dashboards, and modeling financial exposure early.

Keywords

Alternative Specialty Model (ASM)

ASM-Heart Failure (ASM-HF)

CMMI mandatory demonstration

episode-based accountability model

NPI-level two-sided financial risk

Medicare Part B payment adjustments (-9% to +9%)

heart failure episode-based cost measure (50/50 quality-cost weighting)

MIPS/MVP reporting waiver

prescription confirmation for attribution (NPI prescribing visibility)

HF quality measures (beta-blocker, ACEi/ARB/ARNI, BP control, KCCQ/MLHFQ, CV admissions)